Prevymis (letermovir) - Merck (MSD)
VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol (clinicaltrials.gov) - Dec 17, 2025 - P=N/A | N=290 | Not yet recruiting | Sponsor: University of Rome Tor Vergata 
Biomarker • New trial • Bone Marrow Transplantation • Cytomegalovirus Infection • Transplantation
http://clinicaltrials.gov/ct2/show/NCT07286461
 
Dec 17, 2025
 
Prev Next